All members have the option of attending our various HTC-centric events which include:
Location: New York City, NY Please confirm that you can commit to attend the entire meeting before registering. If you have questions regarding this registration please contact Sean Singh at Read the full article...
Date: May 10th - 12th (Buenos Aires, Argentina) Click here for info.
Location: Washington, DC Please contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727.688.2568.
Date: Thursday, June 15, 2023 Time: 1:30pm - 2:30pm ET TOPIC: Discover ALTUVIIIO™, A New Treatment Option for Your Patients, and the Customized Support Services Designed to Assist You OBJECTIVES: Read the full article...
Date: June 16th - 18th (San Antonio, TX) Click here for info.
Date: June 24th - 28th (Montreal, Canada) Click here for info.
Date: Thursday, June 29, 2023 Time: 2:00pm - 3:00pm ET TOPIC: Value Based Agreements with Payers OBJECTIVES: Takeda is excited to share more information about the transition from transactional relationships Read the full article...
Date: July 10th - 12th (Washington, DC) Click here for info.
Date: Thursday, July 13, 2023 Time: 2:00pm - 3:00pm ET TOPIC: Gene Therapy Update OBJECTIVES: Review the status of Roctavian and Hemgenix, gene therapy products and the Alliance contracts with the Read the full article...
Date: Tuesday, August 8, 2023 Time: 1:00pm - 2:00pm ET TITLE: HTC preparation for ROCTAVIAN ™ (valoctocogene roxaparvovec-rvox) OBJECTIVE: Learn about eligibility testing, ordering, storing, handling and administering ROCTAVIAN TARGET Read the full article...
Date: August 17th - 19th (National Harbor, MD) Click here for info.
Date: Tuesday, August 22, 2023 Time: 2:00pm - 3:00pm ET The webinar will review how to stay compliant with USP 797 SOP’s Training Competencies Task Management Reporting Alerting Elimination of Read the full article...
Date: September 18th - 22nd Click here for info.
Date: Wednesday, September 20, 2023 Time: 1:00pm - 2:00pm ET TITLE: Case Discussion: Adult Severe Type 3 von Willebrand Disease Patient OBJECTIVE: In case you missed it at the National Read the full article...
Date: Wednesday, October 4, 2023 Time: 1:00pm - 2:00pm ET TITLE: An injectable, extended half-life recombinant, glycopegylated factor VIII concentrate for Hemophilia A OBJECTIVE: Provide a clinical overview of Esperoct Read the full article...
Venue: The St. Anthony Hotel Location: San Antonio, Texas Please contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568. DRAFT AGENDA: Oct. 8th – Welcome Reception Read the full article...
Date: Thursday, October 12, 2023 Time: 1:00pm - 2:00pm ET TITLE: A Label Update on Rebinyn, (Coagulation Factor IX (Recombinant), GlycoPEGylated: FDA Approval for a Prophylaxis Indication for Persons with Read the full article...
Date: October 18th - 20th (Atlanta, GA) Click here for info.
Date: Tuesday, October 24, 2023 Time: 2:00pm - 3:00pm ET TITLE: A Clinical Overview and Update from Sanofi for Efanesoctocog Alfa, A High Sustained Factor VIII Therapy OBJECTIVES: Highlighting both Read the full article...
Date: Tuesday, November 7, 2023 Time: 2:00pm - 3:00pm ET TITLE: Case Studies of Using BeneFix® (Coagulation Factor IX ) in Different Hemophilia B Patient Populations in an Evolving Treatment Read the full article...
